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Dear Editor
  It is essential that all cases of variant Creutzfeldt-Jakob disease (vCJD) are reported as 
the incidence and geographic distribution of cases inform public health policy. Validated 
criteria for the classification of cases of suspected vCJD   [1]   have been agreed on internation-
ally and contain obligatory preconditions, the presence of specific clinical features, and the 
results of specialist investigations, including the ‘pulvinar sign’ on MRI brain scan. A de-
finitive diagnosis of vCJD requires neuropathological confirmation, either at brain biopsy or 
autopsy.
    The case described by Adanipar et al. [2] has been reported as a case of ‘probable variant 
Creutzfeldt-Jakob disease’. However, although the clinical features would be compatible with 
this condition, other characteristics of the case make this diagnosis unlikely. One of the pre-
conditions for the diagnosis of vCJD is that there should be ‘no evidence of a familial form of 
TSE’, but the authors have identified a P102L mutation, an abnormality associated with the 
familial prion disease Gerstmann-Straussler disease  [3] . The codon 129 genotype was hetero-
zygous, which has not been identified, to date, in any definite or probable case of vCJD. The 
MRI scan images published in the article show high signal in the caudate and lentiform nuclei, 
appearances seen in sporadic CJD   [4]  , and not the ‘pulvinar sign’ which is characteristic of 
vCJD.
    The case reported is of significant interest, but the suggested diagnosis of vCJD cannot 
be regarded as correct unless there is neuropathological verification of this diagnosis.
  Yours  sincerely,
  The  EUROCJD  Group 
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